FDA CDS Guidance: What’s Changed and Who Cares
What the 2026 FDA CDS guidance covers (and what it doesn’t) The FDA’s January 2026 update to its Clinical Decision Support (CDS) guidance is not […]
What the 2026 FDA CDS guidance covers (and what it doesn’t) The FDA’s January 2026 update to its Clinical Decision Support (CDS) guidance is not […]
How the pelvic floor affects erections Erectile function depends not only on arterial inflow and neural signaling, but also on the integrity and coordination of […]
What is PSSD (and how it differs from common SSRI side effects) Post-SSRI sexual dysfunction (PSSD) is a term used to describe a persistent cluster […]
TEFCA basics The Trusted Exchange Framework and Common Agreement (TEFCA) is the U.S. government’s attempt to create a nationwide, interoperable floor for health information exchange. […]
Why Payment Logic for Digital Care Is Shifting Heading into 2026 As 2025 closes, the most consequential changes in digital health are not coming from […]
AI-SaMD in 2025: Why the FDA Shifted from Approval to Lifecycle Control In 2025, the regulatory conversation around AI-enabled medical software changed in a fundamental […]
TEFCA as the “Rule of the Road” for Scaling Connected Health As connected health ecosystems grow more complex, interoperability is no longer a matter of […]
Why Patient Monitors Became a Cybersecurity Flashpoint in 2025 In 2025, connected patient monitors moved from the background of hospital infrastructure to the center of […]
Digital Health Economy & Reimbursement: What Fundamentally Changed in 2025 The defining shift of 2025 was not technological, but economic. Digital health finally moved from […]
Introduction The landscape of liver disease treatment is undergoing a major transformation, and for the first time, diabetes medications, and not traditional hepatology drugs, are […]